Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NVZMF will - over the next 2 Weeks and hit - by . In that time frame, NVZMF's share price is expected to range between - and -.
BearishAverageBullishNVZMF shares remained flat 0 in Thursday, July 31, 2025's trading session, starting and closing at a previous close of $64.37 to move at $64.37. The stock demonstrated notable intraday movement (see NVZMF's key stats for a full breakdown), fluctuating between $64.37 and $72.10, a +12.01% trading range. While recent weeks have seen some volatility, NVZMF has managed to secure a -6.34% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 230 shares changing hands, 70 more than the previous session. This amounted to $14.81K in total market activity.
Will NVZMF Continue Its Trend?
According to analyst ratings and projections for NVZMF, Novozymes A/S shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for NVZMF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the NVZMF stock forecast, now is not the best time to buy NVZMF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on NVZMF covering social and institutional perspectives.
NVZMF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NVZMF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 27.27% to 38.27%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 47.71%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.12%, maintains a neutral outlook for the long term. Insights into NVZMF's shareholder base show how institutional investors are positioning themselves during these momentum shifts